Vorinostat Completed Phase 2 Trials for Recurrent Adult Soft Tissue Sarcoma / Stage III Adult Soft Tissue Sarcoma / Stage IV Adult Soft Tissue Sarcoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00937495Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma